Dendritic Lipopeptide Nanovaccines Orchestrate Multi‐Pattern Recognition Receptors Activation and Potentiate Antitumor Immunity
Advanced Materials · 2026-07 · 38 (38)
DOI: 10.1002/adma.73533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 01.06.2026. Verfasst von Muhetaerjiang Mamuti und 8 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of High Performance Polymer Materials & Technology and State Key Laboratory of Analytical Chemistry For Life Science, School of Ch…. Hauptthemen laut MEDLINE: Nanovaccines, Lipopeptides, Cancer Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Basic Research Program of Jiangsu Province.
Abstract (Originalsprache)
Precise control over the spatial and temporal delivery of antigens and adjuvants is essential for eliciting effective and durable immune responses. Here, we report a self‐assembling nanovaccine platform based on dendritic lipopeptides (DLPs) that integrate delivery and immune‐stimulation through a structurally defined design. DLPs are constructed by conjugating structurally optimized lipid tails to second‐generation lysine‐ or arginine‐rich dendritic scaffolds. Systematic engineering of the lipid domain allows for precise fine‐tuning of the amphiphilic structure, yielding molecular candidates with significantly enhanced TLR2/4 agonist activity. These structures facilitate antigen uptake and cross‐presentation by APCs in a spatiotemporally regulated manner. Co‐assembly with lipidated peptide antigens and a lipid‐modified TLR7/8 agonist yields nanoscale vaccines capable of orchestrating synergistic multi‐pattern recognition receptor (PRR) activation. In murine melanoma and colorectal tumor models, these nanovaccines elicit robust cytotoxic T lymphocyte responses, enhance antigen‐specific killing by up to 40%, and induce significant tumor regression. This work presents a chemically defined, modular nanoplatform that mimics key features of pathogen‐like immunity and provides a rational strategy for engineering minimalist cancer vaccines with high efficacy and translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of High Performance Polymer Materials & Technology and State Key Laboratory of Analytical Chemistry For Life Science, School of Chemistry, Nanjing University, Nanjing, China.
- State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
- Department of Oncology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University, Nanjing, China.
ORCID-Profile: Xiqun Jiang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Basic Research Program of Jiangsu Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Mamuti, M., Zhu, D., Yin, C., Zhang, X., Yu, Q., Jin, Z., Jiang, L., Chen, W., & Jiang, X. (2026). Dendritic Lipopeptide Nanovaccines Orchestrate Multi‐Pattern Recognition Receptors Activation and Potentiate Antitumor Immunity. Advanced Materials, 38(38). https://doi.org/10.1002/adma.73533
Vancouver
Mamuti M, Zhu D, Yin C, Zhang X, Yu Q, Jin Z, et al. Dendritic Lipopeptide Nanovaccines Orchestrate Multi‐Pattern Recognition Receptors Activation and Potentiate Antitumor Immunity. Advanced Materials. 2026;38(38). doi:10.1002/adma.73533
BibTeX
@article{Mamuti2026,
author = {Mamuti, Muhetaerjiang and Zhu, Dan and Yin, Chenxi and Zhang, Xuejian and Yu, Qinran and Jin, Zhetong and Jiang, Lei and Chen, Weizhi and Jiang, Xiqun},
title = {Dendritic Lipopeptide Nanovaccines Orchestrate Multi‐Pattern Recognition Receptors Activation and Potentiate Antitumor Immunity},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {38},
doi = {10.1002/adma.73533}
}
EUVIMED